MarketCap
Immuron Limited IMRN
€ 0.86
-0.01%
Facebook
X
Telegram
Land |
 Australien |
IPO-Jahr |
2017 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
231 M |
Marktkapitalisierung |
$ 222 M |
EBITDA (LTM) |
$ -5.34 M |
P/E (LTM) |
-0.420354 |
P/S (LTM) |
30.107031 |
EPS (LTM) |
-2.26 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.89 | -6.44 % | $ 1.27 B | Nasdaq Capital Market |  Israel |
 |
Zoetis
ZTS
|
$ 80.89 | -0.17 % | $ 35.9 B | NYSE,SPB |  USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.19 | -1.95 % | $ 1.55 M | Nasdaq Global Select Market | USA |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.28 | -1.99 % | $ 223 M | Nasdaq Global Select Market |  Britain |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 73.0 | -4.87 % | $ 5.42 B | Nasdaq Global Select Market | USA |
 |
Karyopharm Therapeutics
KPTI
|
$ 0.48 | -6.34 % | $ 5.25 K | Nasdaq Global Select Market | USA |
 |
MediciNova
MNOV
|
$ 1.41 | 1.44 % | $ 69.2 M | Nasdaq Global Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 2.01 | -3.83 % | $ 17.8 M | Nasdaq Global Select Market | USA |
 |
MediWound Ltd.
MDWD
|
$ 12.1 | 0.83 % | $ 329 M | Nasdaq Global Select Market | Israel |
 |
SELLAS Life Sciences Group
SLS
|
$ 11.35 | -1.69 % | $ 1.24 B | Nasdaq Capital Market | USA |
 |
Precigen
PGEN
|
$ 6.05 | -2.34 % | $ 1.89 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 5.3 | 0.95 % | $ 86.7 M | Nasdaq Global Select Market | Israel |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.27 | -0.87 % | $ 252 M | Nasdaq Global Select Market | USA |
 |
Avidity Biosciences
RNA
|
$ 8.04 | -1.93 % | $ 1.11 B | Nasdaq Global Select Market | USA |
 |
Summit Therapeutics
SMMT
|
$ 14.5 | -6.3 % | $ 10.8 B | Nasdaq Global Select Market | Britain |
 |
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | USA |
 |
Генетико
GECO
|
- | - | - | MOEX |  Russia |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 41.71 | 0.52 % | $ 4.78 B | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market |  Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | Israel |
 |
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market | Britain |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | China |
 |
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market |  Belgium |
 |
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | China |
 |
Galapagos NV
GLPG
|
- | - | $ 1.83 B | Nasdaq Global Select Market | Belgium |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 0.88 | -7.06 % | $ 93.9 M | Nasdaq Global Market | Britain |
 |
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | USA |
 |
Viela Bio, Inc.
VIE
|
- | - | $ 2.91 B | Nasdaq Global Select Market | USA |
 |
Aphria Inc.
APHA
|
- | -0.45 % | $ 4.87 B | Nasdaq Global Select Market |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
- | -0.90 % | $ 104 M | Nasdaq Capital Market | USA |
 |
Chiasma, Inc.
CHMA
|
- | -6.00 % | $ 238 M | Nasdaq Global Select Market | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
- | - | $ 376 M | Nasdaq Global Market | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
- | 0.38 % | $ 12.9 M | Nasdaq Global Select Market | Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
- | 2.07 % | $ 34.4 M | Nasdaq Capital Market | USA |
 |
Cerecor Inc.
CERC
|
- | -1.68 % | $ 283 M | Nasdaq Capital Market | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
- | - | $ 1.63 B | Nasdaq Global Select Market | USA |
 |
Auris Medical Holding Ltd.
EARS
|
- | -1.77 % | $ 39.2 M | Nasdaq Capital Market |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
- | 0.34 % | $ 2.98 B | Nasdaq Global Select Market,SPB | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
- | 1.3 % | $ 27.7 M | Nasdaq Global Select Market | France |
 |
GW Pharmaceuticals plc
GWPH
|
- | - | $ 6.81 B | Nasdaq Global Select Market | Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
- | - | $ 1.7 B | Nasdaq Global Select Market | USA |
 |
Liminal BioSciences
LMNL
|
- | - | $ 256 M | Nasdaq Global Market | Canada |
 |
Neos Therapeutics, Inc.
NEOS
|
- | -2.54 % | $ 57.2 M | Nasdaq Global Market | USA |